Received May 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | K25M5 | IM / LL |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 2 | Y005366 | IM / RL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 2 | LK6655 | IM / LL |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 2 | 2096663 | PO / MO |
5 hours post vaccination, patient developed a red facial rash and had an episode of choking and small spit up of formula. She was assessed in office 1 hour after reaction, 6 hours after vaccines, and facial rash had resolved to mild erythema to forehead. She had normal assessment with clear lungs.
None
None
None; Tylenol post vaccination
None
None